Ets variant 3

ETV3
Identifiers
Aliases ETV3, METS, PE-1, PE1, bA110J1.4, ETS variant 3
External IDs MGI: 1350926 HomoloGene: 21085 GeneCards: ETV3
Orthologs
Species Human Mouse
Entrez

2117

27049

Ensembl

ENSG00000117036

ENSMUSG00000003382

UniProt

P41162

Q8R4Z4

RefSeq (mRNA)

NM_001145312
NM_005240

NM_001083318
NM_001286844
NM_012051

RefSeq (protein)

NP_001138784.1
NP_005231.1

NP_001076787.1
NP_001273773.1
NP_036181.3

Location (UCSC) Chr 1: 157.12 – 157.14 Mb Chr 3: 87.53 – 87.54 Mb
PubMed search [1] [2]
Wikidata
View/Edit HumanView/Edit Mouse

Ets variant 3 is a protein that in humans is encoded by the ETV3 gene. [3]

References

Further reading

  • Klemsz, M; Hromas, R; Raskind, W; Bruno, E; Hoffman, R (1994). "PE-1, a novel ETS oncogene family member, localizes to chromosome 1q21-q23". Genomics. 20 (2): 291–4. doi:10.1006/geno.1994.1169. PMID 8020980. 
  • Hester, K. D.; Verhelle, D; Escoubet-Lozach, L; Luna, R; Rose, D. W.; Glass, C. K. (2007). "Differential repression of c-myc and cdc2 gene expression by ERF and PE-1/METS". Cell cycle (Georgetown, Tex.). 6 (13): 1594–604. doi:10.4161/cc.6.13.4336. PMID 17525531. 
  • Anney, R. J. L.; Lasky-Su, J.; ó'Dúshláine, C.; Kenny, E.; Neale, B. M.; Mulligan, A.; Franke, B.; Zhou, K.; Chen, W.; Christiansen, H.; Arias-Vásquez, A.; Banaschewski, T.; Buitelaar, J.; Ebstein, R.; Miranda, A.; Mulas, F.; Oades, R. D.; Roeyers, H.; Rothenberger, A.; Sergeant, J.; Sonuga-Barke, E.; Steinhausen, H.; Asherson, P.; Faraone, S. V.; Gill, M. (2008). "Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study". American Journal of Medical Genetics Part B. 147B (8): 1369–1378. doi:10.1002/ajmg.b.30871. PMID 18951430. 
  • Sawka-Verhelle, D; Escoubet-Lozach, L; Fong, A. L.; Hester, K. D.; Herzig, S; Lebrun, P; Glass, C. K. (2004). "PE-1/METS, an antiproliferative Ets repressor factor, is induced by CREB-1/CREM-1 during macrophage differentiation". Journal of Biological Chemistry. 279 (17): 17772–84. doi:10.1074/jbc.M311991200. PMID 14754893. 
  • Klappacher, G. W.; Lunyak, V. V.; Sykes, D. B.; Sawka-Verhelle, D; Sage, J; Brard, G; Ngo, S. D.; Gangadharan, D; Jacks, T; Kamps, M. P.; Rose, D. W.; Rosenfeld, M. G.; Glass, C. K. (2002). "An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation". Cell. 109 (2): 169–80. doi:10.1016/S0092-8674(02)00714-6. PMID 12007404. 
  • Mesquita, B; Lopes, P; Rodrigues, A; Pereira, D; Afonso, M; Leal, C; Henrique, R; Lind, G. E.; Jerónimo, C; Lothe, R. A.; Teixeira, M. R. (2013). "Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes". Breast Cancer Research and Treatment. 138 (1): 37–45. doi:10.1007/s10549-013-2408-2. PMID 23329352. 
  • El Kasmi, K. C.; Smith, A. M.; Williams, L.; Neale, G.; Panopoulos, A. D.; Watowich, S. S.; Häcker, H.; Foxwell, B. M.; Murray, P. J. (2007). "Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway". Journal of immunology (Baltimore, Md. : 1950). 179 (11): 7215–7219. doi:10.4049/jimmunol.179.11.7215. PMID 18025162. 


This article is issued from Wikipedia - version of the 7/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.